GREAT VALLEY ADVISOR GROUP, INC.

Position in SMMT — Summit Therapeutics Inc.

CIK 1769897 WILMINGTON, DE

Position in SMMT

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$376,488

-$109,646 QoQ

Shares Held

25,840

+0.8% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#121

of 242 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

GREAT VALLEY ADVISOR GROUP, INC. holds $5,771,539 across 13 Biotechnology names. SMMT ranks #5 (6.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,947	$2,734,138
2	CELC	Celcuity Inc.	5,591	$584,930
3	INCY	Incyte Corp	5,040	$571,334
4	VRTX	Vertex Pharmaceuticals Inc / Ma	874	$434,142
5	SMMT	Summit Therapeutics Inc. This page	25,840	$376,488
6	JAZZ	Jazz Pharmaceuticals plc	1,080	$260,247
7	REGN	Regeneron Pharmaceuticals, Inc.	379	$236,321
8	BBIO	BridgeBio Pharma, Inc.	2,700	$201,096

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$376,488	25,840	+0.8%	Shares	Sole	2026-08-10
2026-03-31	$486,134	25,640	0.0%	Shares	Sole	2026-05-11
2025-12-31	$448,443	25,640	-0.1%	Shares	Sole	2026-02-12
2025-09-30	$530,404	25,673	+2.0%	Shares	Sole	2025-11-14
2025-06-30	$535,681	25,173	+0.2%	Shares	Sole	2025-08-14
2025-03-31	$484,815	25,133	+0.1%	Shares	Sole	2025-05-08
2024-12-31	$447,927	25,101	+0.4%	Shares	Sole	2025-02-24
2024-09-30	$547,500	25,000	-26.5%	Shares	Sole	2024-11-12
2024-06-30	$265,379	34,023	0.0%	Shares	Sole	2024-07-16
2024-03-31	$140,855	34,023	0.0%	Shares	Sole	2024-05-06
2023-12-31	$88,800	34,023	0.0%	Shares	Sole	2024-02-06
2023-09-30	$63,623	34,023	0.0%	Shares	Sole	2023-11-07
2023-06-30	$85,397	34,023	0.0%	Shares	Sole	2023-08-10
2023-03-31	$59,540	34,023	—	Shares	Sole	2023-05-03
No filing history on record for this holder in this stock.